Loperamide Contraindications in Adults with Diarrhea
Loperamide is contraindicated in adults with diarrhea who have fever, bloody stools, suspected inflammatory diarrhea, acute dysentery, acute ulcerative colitis, or pseudomembranous colitis associated with antibiotics. 1
Specific Contraindications
Loperamide should not be used in adults with:
- Known hypersensitivity to loperamide hydrochloride or any excipients 1
- Abdominal pain in the absence of diarrhea 1
- Acute dysentery characterized by blood in stools and high fever 1
- Acute ulcerative colitis 1
- Bacterial enterocolitis caused by invasive organisms including:
- Salmonella
- Shigella
- Campylobacter 1
- Pseudomembranous colitis (e.g., Clostridium difficile) associated with broad-spectrum antibiotics 1
- Grade 3 and 4 immunotherapy-induced diarrhea and colitis 2
Special Considerations for Cancer Patients
For cancer patients, additional precautions apply:
- In patients with chemotherapy-induced diarrhea, loperamide can be started at an initial dose of 4 mg followed by 2 mg every 2–4 hours or after every unformed stool 2
- Maximum daily dose is 16 mg 2
- Monitor patients using high-dose loperamide for risk of paralytic ileus 2
- For immunotherapy-related diarrhea:
Algorithmic Approach to Loperamide Use in Adults
First priority: Assess for contraindications
- Check for fever, blood in stool, abdominal pain without diarrhea
- Rule out inflammatory bowel conditions or infectious causes
If no contraindications exist:
Monitor for:
- Development of fever after starting treatment (discontinue if occurs)
- Signs of paralytic ileus
- Worsening of symptoms (discontinue if occurs)
Pitfalls to Avoid
- Using loperamide before addressing rehydration needs 3
- Continuing loperamide if symptoms worsen or fever develops 3
- Using loperamide in patients with bloody diarrhea without ruling out infectious causes 3
- Exceeding the maximum daily dose of 16 mg 2
- Failing to consider alternative therapies (such as tincture of opium) when loperamide is contraindicated 2
Loperamide remains an effective first-line pharmacologic therapy for uncomplicated diarrhea in adults, with studies showing superior efficacy compared to placebo and bismuth subsalicylate 4, 5. However, proper patient selection is critical to ensure safety and effectiveness.